SCHEMBL1008555

SCHEMBL1008555

NN(C(=O)OCc1ccccc1)C1CCCCC1

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 1/20 0.56
SIGMAR1 Q99720 1/20 0.50
ALDH1A1 P00352 3/20 0.47
EPHX1 P07099 1/20 0.46
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
TSHR P16473 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
TRPM8 Q7Z2W7 2/20 0.44
CHRM2 P08172 1/20 0.44
CHRM5 P08912 1/20 0.44
CHRM1 P11229 1/20 0.44
CHRM3 P20309 1/20 0.44
LMNA P02545 1/20 0.44
MAPT P10636 1/20 0.44
HTT P42858 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
CYP2C19 P33261 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3564278 0.98 ENPP2 (0.54) ENPP2SIGMAR1ALDH1A1EPHX1KMT2A
SCHEMBL21872794 0.86 ENPP2 (0.60) ENPP2SIGMAR1ALDH1A1EPHX1MEN1
SCHEMBL4205099 0.82 SIGMAR1 (0.63) ENPP2SIGMAR1ALDH1A1MEN1KMT2A
SCHEMBL29068551 0.81 ENPP2 (0.52) ENPP2SIGMAR1TSHRL3MBTL1TRPM8
SCHEMBL6193454 0.81 ENPP2 (0.52) ENPP2SIGMAR1ALDH1A1EPHX1TSHR
SCHEMBL8029227 0.81 SIGMAR1 (0.64) ENPP2SIGMAR1ALDH1A1MEN1KMT2A
SCHEMBL190556 0.80 ENPP2 (0.57) ENPP2SIGMAR1ALDH1A1EPHX1L3MBTL1
SCHEMBL22285161 0.80 ENPP2 (0.57) ENPP2SIGMAR1ALDH1A1EPHX1L3MBTL1
SCHEMBL13684267 0.80 L3MBTL1 (0.63) ENPP2SIGMAR1L3MBTL1
SCHEMBL4056164 0.80 ENPP2 (0.54) ENPP2SIGMAR1ALDH1A1EPHX1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2464634-B1 REGIOSELECTIVE PREPARATION OF 2-AMINO-5-TRIFLUOROMETHYLPYRIMIDINE DERIVATIVES BOEHRINGER INGELHEIM INT (DE) 2016-11-30 EP disclosed
US-8933227-B2 Selective synthesis of functionalized pyrimidines BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-01-13 US disclosed
US-20140213787-A1 REGIOSELECTIVE PREPARATION OF 2-AMINO-5-TRIFLUOROMETHYLPYRIMIDINE DERIVATIVES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-07-31 US disclosed
US-8729265-B2 Regioselective preparation of 2-amino-5-trifluoromethylpyrimidine derivatives BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-05-20 US disclosed
US-20130079519-A1 REGIOSELECTIVE PREPARATION OF SUBSTITUTED PYRIMIDINES DURAN ADIL (DE) 2013-03-28 US disclosed
US-8334383-B2 Regioselective preparation of substituted pyrimidines BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-12-18 US disclosed
US-20120172596-A1 REGIOSELECTIVE PREPARATION OF 2-AMINO-5-TRIFLUOROMETHYLPYRIMIDINE DERIVATIVES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-07-05 US disclosed
US-20110190499-A1 SELECTIVE SYNTHESIS OF FUNCTIONALIZED PYRIMIDINES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-08-04 US disclosed
US-20110077403-A1 REGIOSELECTIVE PREPARATION OF SUBSTITUTED PYRIMIDINES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-03-31 US disclosed
EP-2268622-A1 REGIOSELECTIVE PREPARATION OF SUBSTITUTED PYRIMIDINES Boehringer Ingelheim International GmbH (DE) 2011-01-05 EP disclosed
WO-2009115587-A1 REGIOSELECTIVE PREPARATION OF SUBSTITUTED PYRIMIDINES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-09-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110190499-A1 SELECTIVE SYNTHESIS OF FUNCTIONALIZED PYRIMIDINES DPYD, TYMS, UMPS ENPP2 2461/4885SIGMAR1 3346/4885ALDH1A1 727/4885
US-20140213787-A1 REGIOSELECTIVE PREPARATION OF 2-AMINO-5-TRIFLUOROMETHYLPYRIMIDINE DERIVATIVES DPYD, CYP3A5, PAICS ENPP2 2121/4885SIGMAR1 3784/4885ALDH1A1 172/4885
US-20110077403-A1 REGIOSELECTIVE PREPARATION OF SUBSTITUTED PYRIMIDINES TYMS, DPYD, TYMP ENPP2 2350/4885SIGMAR1 2773/4885ALDH1A1 751/4885
US-20120172596-A1 REGIOSELECTIVE PREPARATION OF 2-AMINO-5-TRIFLUOROMETHYLPYRIMIDINE DERIVATIVES DPYD, HRH2, TYMS ENPP2 2645/4885SIGMAR1 1022/4885ALDH1A1 1048/4885
US-20130079519-A1 REGIOSELECTIVE PREPARATION OF SUBSTITUTED PYRIMIDINES TYMS, DPYD, TYMP ENPP2 2241/4885SIGMAR1 2596/4885ALDH1A1 775/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.